Beneficial Effects of Capparis Spinosa Honey on the Immune Response of Rats Infected with Toxoplasma Gundii

  • Received : 2017.05.04
  • Accepted : 2017.06.13
  • Published : 2017.06.30


Objectives: The Toxoplasma gondii (T. gondii) is an intracellular opportunistic protozoan parasite that infects approximately one-third of the human population worldwide. Honey has long been used for treatment of many diseases in folk medicine. Honey has exhibited significant anthelmintic, nematicidal and anti-protozoal activities. This study was conducted to investigate the immunological patterns in rats infected with T. gondii who were treated orally with supplemented 15% Capparis spinosa honey (Saudi Arabia) for a period of 28 days. Methods: Immunoglobulin M, immunoglobulin G, and cytokines were detected by using enzyme-linked immunosorbent assays (ELISAs). In addition, the mortality and the morbidity rates were assessed. Results: Oral administration of Capparis spinosa honey as a natural food additive was experimentally shown to increase the antibody titer; furthermore, compared with the rats in the control group, the levels of the sera cytokines ($IFN-{\gamma}$, IL-1 and IL-6) were consistently higher at day 7 post-infection in the infected rats treated with oral supplements of Capparis spinosa honey. Conclusion: Orally administered supplements of Capparis spinosa honey increased both the antibody titer and the cytokines ($IFN-{\gamma}$, IL-1 and IL-6) levels in rats infected with T. gondii.


  1. Joynson DH, Wreghitt TG. Toxoplasmosis: a comprehensive clinical guide. United Kingdom: Cambridge University Press; 2001. 412 p.
  2. McConkey GA, Martin HL, Bristow GC, Webster JP. Toxoplasma gondii infection and behaviorr - location, location, location?. J Exp Biol. 2103;216(1):113-9.
  3. Dawkins R. The extended phenotype: the long reach of the gene. New York: Oxford University Press; 1999. 336 p.
  4. Luder CG, Giraldo-Velasquez M. Sendtner M, Gross U. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp Parasitol. 1999;93(1):23-32.
  5. Vidotto O, Navarro IT, Mitsuka R, Freire RL. [Estudos epidemiologicos da toxoplasmose em suinos da regiao de Londrina, PR]. Semina Cien Agrarias. 1990;11(1):53-9. Portuguese.
  6. Dubey JP. Advances in the life cycle of Toxoplasma gondii. Int J Parasitol. 1998;28(7):1019-24.
  7. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12-13):1217-58.
  8. Ruffolo BB, Toledo RS, Martins FDC, Bugni FM, Costa LD, Marana ERM, et al. Isolation and genotyping of Toxoplasma gondii in seronegative urban rats and presence of antibodies in communicating dog in Brazil. Rev Inst Med Trop Sao Paulo. 2016;58:28.
  9. Molan P. Why honey is effective as a medicine. 2. the scientific explanation of its effects. Bee world. 2001;82(1):22-42.
  10. Hegazi AG. Antimicrobial activity of different Egyptian honeys as comparison of Saudi Arabia honey. Research Journal of Microbiology. 2011;6(5):488-95.
  11. Hegazi AG, Abd Allah FM. Antimicrobial activity of different Saudi Arabia honeys. Global Veterinaria. 2012;9(1):53-9.
  12. Hegazi AG, FK Abd El Hady, MA El Ansari, F Abd Allah, NAM Saleh. Influence of storage on chemical composition and antimicrobial activity of Coriander (Coriandrum sativum) honey. Egypt J Vet Sci. 2002;36:17-30.
  13. Hegazi AG, Moharm NZ, Allah FA, Nour MS, Khair AM. Antibacterial activity of different Egyptian honeys in relation to some bee products. Egypt J Vet Sci. 2002;36:31-42.
  14. Al-Waili NS. Investigating the antimicrobial activity of natural honey and its effect on the pathogenic bacterial infection of surgical wounds and conjunctiva. J Med Food. 2004;7(2):210-22.
  15. French VM, Cooper RA, Molan PC. The antibacterial activity of honey against coagulase-negative staphylococci. J Antimicrob Chemother. 2005;56(1):228-31.
  16. Hegazi AG, Abd El Hady FK. Influence of honey on the suppression of human low density lipoprotein (LDL) peroxidation (In vitro): Evid Based Complement Alternat Med. 2009;6(1):113-21.
  17. Hegazi A, Al Tahtawy RHM, Allah FA, Abdou AM. Antitumor and antioxidant activity of honey in mice bearing ehrlich ascites carcinoma. AJCR. 2014;7(3):208-14.
  18. Hegazi A, Abdou AM. Allah FA. Influence of honey on immune response against newcastle disease vaccine. IJBAV. 2013;2(1):1-5.
  19. Hegazi AG, Abdel-Rahman EH, Abd Allah F, Abdou AM. Influence of honey on immune status in mice-bearing ehrlich carcinoma. J Clin Cell Immunol. 2015;6(1):1000295.
  20. Salkova D, Panayotova-Pencheva MS. Movsesyan SO. Some bee products as antiparasitic remedies. Russian Journal of Parasitology. 2015;75-8.
  21. Azim MK, Perveen H, Mesaik MA, Simjee SU. Antinociceptive activity of natural honey in thermal-nociception models in mice. Phytother Res. 2007;21(2):194-7.
  22. Mesaik MA, Azim MK, Mohiuddin S. Honey modulates oxidative burst of professional phagocytes. Phytother Res. 2008;22(10):1404-8.
  23. Sajid M, Azim MK. Characterization of the nematicidal activity of natural honey. J Agric Food Chem. 2012;60(30):7428-34.
  24. Hegazi AG, El-Fadaly HA, Barakat AM, Abou-El-Doubal SKA. In vitro effects of some bee products on T. gondii Tachyzoites. Global Veterinaria. 2014;13(6):1043-50.
  25. Dubey JP. Advances in the life cycle of Toxoplasma gondii. Int J Parasitol. 1998;28(7):1019-24.
  26. Elfadaly HA, Hassanain MA, Shaapan RM, Barakat AM, Toaleb, NI. Serological and hormonal assays of murine matern fetal Toxoplasma gondii infection with emphasis on virulent strains. World Journal of Medical Sciences. 2012;7(4):248-54.
  27. Fadaly HA, Soror AH, Barakat AMA, El-Razik KAA. Zoonotic and histopathological aspects of various Toxoplasma gondii strains in femal rats. Afr J Infect Dis. 2015;9(2):32-8.
  28. Stuart MC, Kouimtzi M, Hill SR. WHO Model Formulary 2008. Geneva: World Health Organization; 2009. 126 p. 205 p.
  29. Hassan SE, Toaleb NI, Shaapan RM, Abdel-Rahman EH, Elmahallawy EK. Diagnosis of toxoplasmosis using affinity purified fraction of tachyzoites local isolate. Research Journal of Parasitology. 2016;11:13-9.
  30. Daryani A, Hosseini AZ, Dalimi A. Immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model. Vet Parasitol. 2003;113(2):123-34.
  31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
  32. Voller A, Bidwell DE, Bartlett A, Fleck DG, Perkins M, Oladehin B. Microplate enzyme-immunoassay for toxoplasma antibody. J Clin Pathol. 1976;29(2):150-3.
  33. Roberts CW, Cruickshank SM, Alexander J. Sex-determined resistance to toxoplasma gondii is associated with temporal differences in cytokine production. Infect Immun. 1995;63(7):2549-55.
  34. Steel RGD. Principles and procedures of statistics: a biometrical approach. Michigan: McGraw-Hill; 1997. 666 p.
  35. Remington JS, Krahenbuhl JL. Immunology of Toxoplasma gondii. compr. Immunol. 1982;9:327-71.
  36. Chang HR, Grau GE, Pechere JC. Role of TNF and IL-1 in infection with Toxoplasma gondii. Immunology. 1990;69(1):33-7.
  37. Beaman MH, Pearce MK, Abrams JS, Remington JS. Serum cytokine profile in lethal murine toxoplasmosis. proceed first. Quebec: Inter Congr Biological Response Modifiers; 1991. p. 61.
  38. Favre G, Bessieres MH, Seguela JP. Dosage des IgA sdriques de la toxoplasmose par une methode ELISA. application a 120 cas. Bull Soc Fr Parasitol. 1984;3:139-42.
  39. Turunen H, Vuorio KA, Leinikki PO. Determination of IgG, IgM and IgA antibody responses in human toxoplasmosis by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis. 1983;15:307-11.
  40. Pappas MG, Lunde MN, Hajkowski R, McMahon J. Determination of IgM and IgG antibodies to Toxoplasma using the IFA test, ELISA, and Dot-ELISA procedures. Vet Parasitol. 1986;20(1-3):31-42.
  41. Mohammadzadeh S, Sharriatpanahi M, Hamedi M, Amanzadeh Y, Ebrahimi SES, Ostad SN. Antioxidant power of Iranian propolis extract. Food Chem. 2007;103(3):729-33.
  42. Muhammad A, Oyeronke AO, Solomon EO, Michael AG, Muhammad IC, Farooq AD, et al. Daily consumption of honey: effects on male wister albino rats. International Journal of Food Nutrition and Safety. 2012;1(2):66-74.
  43. Gheldof N, Wang XH, Engeseth NJ. Identification and quantification of antioxidant components of honeys from various floral sources. J Agric Food Chem. 2002;50(21):5870-7.
  44. Woo KJ, Jeong YJ, Park JW, Kwon TK. Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochem Biophys Res Commun. 2004;325(4):1215-22.
  45. Wilson JI, George BO, Umukoro GE. Effects of honey on the histology of liver in adult wistar rats. BLM. 2011;3(1):1-5.
  46. Fiorani M, Accorsi A, Blasa M, Diamantini G, Piatti E. Flavonoids from Italian multifloral honeys reduce the extracellular ferricyanide in human red blood cells. J Agric Food Chem. 2006;54(21):8328-34.
  47. Beaman MH, Abrams JS, Remington JS. Serum cytokine profile in acute and chronic toxoplasma infections of mice: evidence for the role of interleukin-6 in pathogenesis. 1994.
  48. Hunter CA, Subauste CS, Remington JS. The role of cytokines in toxoplasmosis. Biotherapy. 1994;7(3-4):237-47.
  49. Dunay IR, Fuchs A, David Sibley L. Inflammatory monocytes but not neutrophils are necessary to control infection with toxoplasma gondii in mice. Infect Immun. 2010;78(4):1564-70.
  50. Gaddi PJ, Yap GS. Cytokine regulation of immunopathology in toxoplasmosis. Immunol Cell Biol. 2007;85(2):155-9.
  51. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5(10):987-95.
  52. Yarovinsky F, Sher A. Toll-like receptor recognition of toxoplasma gondii. Int J Parasitol. 2006;36(3):255-9.
  53. Masek KS, Hunter CA. Pro-inflammatory responses in macrophages during toxoplasma gondii infection [Internet]. Madame Curie Bioscience Database. Available from:
  54. van Gisbergen KP, Geijtenbeek TB, van Kooyk Y. Close encounters of neutrophils and DCs. Trends Immunol. 2005;26(12):626-31.
  55. Soehnlein O, Drechsler M, Doring Y, Lievens D, Hartwig H, Kemmerich K, et al. Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Mol Med. 2013;5(3):471-81.
  56. Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol. 2001;167(8):4574-84.
  57. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999;340(3):207-14.
  58. Tonks AJ, Cooper RA, Jones KP, Blair S, Parton J, Tonks A. Honey stimulates inflammatory cytokine production from monocytes. Cytokine. 2003;21(5):242-7.
  59. Slavin J. The role of cytokines in wound healing. J Pathol. 1996;178(1):5-10.<5::AID-PATH443>3.0.CO;2-W
  60. Jones LA, Alexander J, Roberts CW. Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol. 2006;28(12):635-42.
  61. Denkers EY, Gazzinelli RT. Regulation and function of T-cellmediated immunity during toxoplasma gondii infection. Clin Microbiol Rev. 1998;11(4):569-88.
  62. R Appelberg, IM Orme, MI Pinto de Souza, MT Silva. In vitro effects of interleukin-4 on interferon-gamma induced macrophage activation. Immunology. 1992;76(4):553-9.
  63. Thomson A, Lotze M. The cytokine handbook. Boston: Academic Press; 2003. p. 227-80.
  64. Subrahmanyam M. A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Burns. 1998;24(2):157-61.
  65. Popa ID, Schiriac EC, Ungureanu D, Cuciureanu R. Immune response in rats following administration of honey with sulfonamides residues. Revista Romana de Medicina de Laborator. 2012;20:63-72.